What If You Could See the Full Picture?

And Build a Roadmap and Budget in Just Days

For early- to- mid-stage biopharma companies the months-long commercialization planning process is complex and daunting, requires extensive external resources, and impedes progress towards long-term success.

Corval’s intelligent, intuitive platform provides you clarity and guidance to navigate the commercialization journey and ensure you don’t miss a single step along the path to getting your treatment to patients in need.

Case Studies

NEW! Pre-Commercial Biopharma Sought to Acquire a Late-Stage Pipeline Asset in Order to Build a Commercial Infrastructure in Support of Its First Product Launch

A pre-commercial biopharma company with a robust pipeline of rare disease assets–the majority in Phase 1 clinical trials–sought to establish a comprehensive commercialization infrastructure… READ MORE

Phase 1 Biopharma Needed to Quickly Develop and Coordinate on a Commercialization Roadmap

The Chief Executive Officer of a clinical-stage biopharmaceutical company developing a novel treatment had just hired a Chief Medical Officer, growing the company from two employees to three. The CEO, a firm believer in the importance of early commercialization planning, immediately… READ MORE

Pre-Commercial Biopharma Sought Resource Planning and Team Alignment

A pre-commercial biopharmaceutical company developing a small-molecule asset for use in oncology was in a late Phase 2 clinical trial and needed immediate assistance to build in-house expertise, accelerate critical business decisions, and set their commercialization journey… READ MORE

Questions? Let's talk

Experience Corval for Yourself